Cargando…
Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis
OBJECTIVES: Real-world evaluation of the performance of the Innova lateral flow immunoassay antigen device (LFD) for regular COVID-19 testing of hospital workers. METHODS: This prospective cohort analysis took place at a London NHS Trust. 5076 secondary care healthcare staff participated in LFD test...
Autores principales: | Lamb, Georgia, Heskin, Joseph, Randell, Paul, Mughal, Nabeela, Moore, Luke SP, Jones, Rachael, Davies, Gary W, Rayment, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340567/ https://www.ncbi.nlm.nih.gov/pubmed/34364950 http://dx.doi.org/10.1016/j.jinf.2021.07.038 |
Ejemplares similares
-
Healthcare worker perceptions of routine asymptomatic SARS-CoV-2 screening using lateral flow assays: A qualitative analysis across two London hospitals.
por: Heskin, Joseph, et al.
Publicado: (2021) -
Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay
por: Pallett, Scott J.C., et al.
Publicado: (2022) -
Association between SARS-CoV-2 exposure and antibody status among healthcare workers in two London hospitals: a cross-sectional study
por: Murongazvombo, Admire S., et al.
Publicado: (2021) -
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
por: Heskin, Joseph, et al.
Publicado: (2022) -
Evaluating the performance characteristics of five lateral flow assays for the detection of the SARS-CoV-2 nucleocapsid antigen
por: Heskin, J., et al.
Publicado: (2022)